Key occasions embrace direct-to-consumer drug platform launches tied to the Trump household, courtroom rulings in opposition to Novo Nordisk over Medicare negotiations, a large jury award in opposition to Johnson & Johnson, UnitedHealth buying a main care group, Novo Nordisk buying Akero Therapeutics, and Bristol Myers Squibb shopping for Orbital Therapeutics.
